Opioid Use Disorder in Pregnancy

Updated 11/8/2017

(NEW) Opioid Use Disorder in Pregnancy White Paper
Actionable Strategies to Improve Management & Outcomes in New York (November 2017)

Press Release: Women’s Health Care Providers in New York State Highlight Strategies to Address Opioid Use Disorder in Pregnancy

Project Overview

Women, Pregnancy, and the Opioid Epidemic in Upstate New York: A Healthcare Provider Educational Approach

The opioid epidemic is an escalating public health concern of the 21st century in the United States and there is an immediate need for a large expansion of treatment, especially for pregnant women. ACOG District II, a member organization for over 4,000 New York State women’s health care providers ensures all women across the state receive high quality care and support and has made examining and addressing opioid use disorder in pregnancy a priority.

ACOG District II, with support from the New York State Health Foundation (NYSHF), embarked on an initiative to educate women’s healthcare providers about the comprehensive management of pregnant women with opioid use disorder. The goal of this initiative is to increase education and awareness on evidence-based guidelines for the care of pregnant women battling opioid addiction and focusing on women’s healthcare providers in upstate New York regions (including rural communities where the impact of addiction is severe). ACOG District II aims to strengthen safety nets for pregnant women by working in concert with the New York State Department of Health, including the New York State Office of Alcohol and Substance Abuse Services (OASAS), and community-based organizations, seeking clinical practice and public policy changes that increase and sustain access to treatment services. 


Top of Page

Opioid Summit

ACOG District II hosted an educational summit on April 27, 2017 at SUNY Upstate Medical University to provide multidisciplinary stakeholders from across the state with an opportunity to collaborate with their colleagues on potential recommendations and solutions to the issue of opioid use disorder in pregnancy. A coordinated, multidisciplinary approach to care and treatment has demonstrated favorable results for pregnant women with opioid use disorder and their infants. As a result of the summit, a white paper is being developed with key recommendations and actionable strategies to improve management and outcomes of opioid use disorder in pregnancy.

Summit Agenda

Opioid Summit Presentations: The Role of Experts Caring for Opioid Use Disorder in Pregnancy

Obstetrics and Gynecology:
Leah Kaufman, MD, FACOG; SUNY Upstate
Opiate Dependence in Pregnancy - The Perspective of a Generalist OB/GYN
Leah Kaufman, MD, FACOG
David Garry, DO, FACOG; Stony Brook Medicine
Caring For Opioid Dependent Women In Pregnancy
David Garry, DO, FACOG

Michele Bode, MD, MPH; Crouse Hospital
Neonatal Abstinence Syndrome: Pediatric Perspective

Michele Bode, MD, MPH

Primary Care & Addiction/Treatment Clinic:
Paul Updike, MD; Sister’s Hospital
Treating Opiate Use Disorder In Pregnancy: A Primary Care Perspective

Paul Updike, MD

Case Management:
Sarah Reckess, Esq.; Center for Court Innovation
The Patient Navigator Program: Serving Justice-Involved Pregnant Women

Sarah Reckess, Esq.

Social Worker / Community Outreach:
Kim Hober, LMSW; University of Rochester Medical Center
Intervention with Chemically Dependent Pregnant Patients

Sarah Reckess, Esq.


Top of Page

Training Opportunities & Courses

ASAM Buprenorphine Waiver Training

Upcoming Live Courses


NYCDOHMH Buprenorphine Trainings (throughout all five boroughs)

For further information, contact: buprenorphine@health.nyc.gov.

For details about upcoming Medication-Assisted Treatment (MAT) trainings, please visit www.pcssmat.org/mat-basics/mat-waiver-training/.


NYSDOH Buprenorphine Trainings:

For information, contact the AIDS Institute, Office of Drug User Health, buprenorphine@health.ny.gov or 1-800-692-8528

University at Buffalo Buprenorphine Waiver Training – Upcoming Courses


Practice Guidelines

ACOG Committee Opinion: Opioid Use and Opioid Use Disorder in Pregnancy

ACOG Patient Safety Bundle: Obstetric Care for Women with Opioid Use Disorder


Best Practices/Model Programs

Caring for Pregnant Opioid Abusers in Vermont: A Potential Model for Non-Urban Areas

Center for Court Innovation Patient Navigator program

Maternal Opiate Medical Support (MOMS) Care Coordination Model


NYS OASAS has Certified Recovery Peer Advocates (CRPA)

SAMHSA Collaborative Approach to the Treatment of Pregnant Women with Opioid Use Disorders

Vermont Oxford Network: Improving Outcomes for Infants and Families Affected by Neonatal Abstinence Syndrome (NAS) – A Universal Training Program

Zero to Three


Top of Page

Relevant Articles & Resources

Chronic Opioid Use During Pregnancy: Fetal & Maternal Implications

Clinical, Ethical, and Legal Considerations Pregnant Women with Opioid Abuse

COWS Scale

Neonatal Abstinence Syndrome and Ethical Approaches to the Identification of Pregnant Women Who Use Drugs

Non-medical Opioid Use & Sources of Opioids Among Pregnant & Non-pregnant Reproductive-aged Women

Opioid Use Disorder in Pregnancy Health Policy & Practice in the Midst of an Epidemic

Prescription Drug Monitoring Programs: A Guide for Healthcare Providers

Rural & Urban Differences in NAS and Maternal Opioid Use


Patient Testimonials & Educational Videos

NYS OASAS Combat Heroin & Prescription Drug Abuse: Real Stories


External Web Links

American Society of Addiction Medicine (ASAM)

Centers for Disease Control and Prevention Prescription Drug Monitoring Program

Children and Family Futures

Governor Cuomo’s Task Force to Combat Heroin

NYSDOH AIDS Institute Office of Drug User Health


NYS OASAS Treatment Availability Dashboard


Providers’ Clinical Support System

Screening Brief Interventions and Referral to Treatment-SBIRT

Substance Abuse Confidentiality Regulations for Health Information Exchanges

Substance Abuse and Mental Health Services Administration (SAMHSA)

Top of Page